Heart Failure Drug Treatment-Inertia, Titration, and Discontinuation: A Multinational Observational Study (EVOLUTION HF) (vol 11, pg 1, 2023)

被引：1
|
作者：
Savarese, G.
Kishi, T.
Vardeny, O.
Eryd, S. Adamsson
Bodegard, J.
Lund, L. H.
Thuresson, M.
Bozkurt, B.
机构：
来源：
JACC-HEART FAILURE | 2023年 / 11卷 / 12期
关键词：
D O I：
10.1016/j.jchf.2023.11.001
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 11 条
  • [1] Heart Failure Drug Treatment- Inertia, Titration, and Discontinuation
    Savarese, Gianluigi
    Kishi, Takuya
    Vardeny, Orly
    Eryd, Samuel Adamsson
    Bodegard, Johan
    Lund, Lars H.
    Thuresson, Marcus
    Bozkurt, Biykem
    JACC-HEART FAILURE, 2023, 11 (01) : 1 - 14
  • [2] Heart failure drug titration, discontinuation, mortality and heart failure hospitalization risk: a multinational observational study (US, UK and Sweden)
    Savarese, Gianluigi
    Bodegard, Johan
    Norhammar, Anna
    Sartipy, Peter
    Thuresson, Marcus
    Cowie, Martin R.
    Fonarow, Gregg C.
    Vaduganathan, Muthiah
    Coats, Andrew J. S.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 (09) : 1499 - 1511
  • [3] Dapagliflozin utilization following hospitalization for heart failure: real-world insights from EVOLUTION HF, a multinational, observational study
    Savarese, G.
    Bozkurt, B.
    Eryd, S. Adamsson
    Bodegard, J.
    Lund, L. H.
    Thuresson, M.
    Vardeny, O.
    Kishi, T.
    EUROPEAN HEART JOURNAL, 2022, 43 : 971 - 971
  • [4] Early treatment of heart failure: a non-interventional observational study programme of patients with heart failure and initiated on dapagliflozin (EVOLUTION HF)
    Rosano, G.
    Gnesi, M.
    Mamza, J. B.
    Morris, T.
    Chioncel, O.
    Coombs, S.
    Eryd, S. Adamsson
    Metra, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 175 - 175
  • [5] TREATMENT OF HEART FAILURE IN CLINICAL PRACTICE: NON-INTERVENTIONAL OBSERVATIONAL STUDY ON PATIENTS WITH HEART FAILURE TREATED WITH DAPAGLIFLOZIN (EVOLUTION-HF ITALY)
    Orso, F.
    Ameri, P.
    Carugo, S.
    Di Lenarda, A.
    Iacoviello, M.
    Indolfi, C.
    Mortara, A.
    Filardi, P. Perrone
    Ungar, A.
    Volpe, M.
    Volterrani, M.
    Granelli, V.
    Mastromauro, F.
    Pluchinotta, F.
    Gnesi, M.
    Rosano, G.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2023, 25
  • [6] Evaluation of Microvascular Rarefaction in Vascular Cognitive Impairment and Heart Failure (CRUCIAL): Study Protocol for an Observational Study (vol 13, pg 18, 2023)
    不详
    CEREBROVASCULAR DISEASES EXTRA, 2023, 13 (01): : 90 - 90
  • [7] Synergistic effects of cardiac resynchronization therapy and drug up-titration in heart failure: is this enough? (vol 1, pg 189, 2015)
    Volpe, Massimo
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2016, 2 (04) : 217 - 217
  • [8] Clinical characteristics and treatment patterns of new users of dapagliflozin for heart failure with reduced ejection fraction: an observational study programme across 12 countries (EVOLUTION HF)
    Rosano, G.
    Mamza, J. B.
    Morris, T.
    Gnesi, M.
    Pardal, M.
    Isvoranu, M.
    Eryd, S. Adamsson
    Cardoso, J. S.
    Chioncel, O.
    Coombs, S.
    Metra, M.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [9] Determining the Feasibility of Spinal Cord Neuromodulation for the Treatment of Chronic Systolic Heart Failure: The DEFEAT-HF Study (vol 4, pg 129, 2016)
    Zipes, D. P.
    Neuzil, P.
    Theres, H.
    Caraway, D.
    Mann, D. L.
    Mannheimer, C.
    Van Buren, P.
    Linde, C.
    Linderoth, B.
    Kueffer, F.
    Sarazin, S. A.
    DeJongste, M. J. L.
    JACC-HEART FAILURE, 2018, 6 (06) : 542 - 542
  • [10] Insulin degludec versus insulin detemir, both in combination with insulin aspart, in the treatment of pregnant women with type 1 diabetes (EXPECT): an open-label, multinational, randomised, controlled, non-inferiority trial (vol 11, pg 86, 2023)
    Mathiesen, E. R.
    Alibegovic, A. C.
    Corcoy, R.
    LANCET DIABETES & ENDOCRINOLOGY, 2023, 11 (08): : E10 - E10
12